Categories: Latest

International society for gene and stem cell therapy convention to be held at Indian Institute of Science (IISC) from November 3-5, 2017

Bengaluru, October 14, 2017: Gene Research Foundation, Bengaluru will be conducting the annual conference on INTERNATIONAL SOCIETY FOR GENE AND STEM CELL THERAPY from November 3-5, 2017 at the prestigious Indian Institute of Science (IISc).  On the occasion, popular Indian cricketer Sreesanth unveiled the White Paper on the current status of Gene and Stem Cell Therapy in India.

The primary aim of ISGCT is to collaborate scientists, physicians, patients, regulatory authorities and industry on one platform to evaluate the progress made in the field of stem cell and gene research, treatment and results.

Dr. Agarwal Hospitals and Gene Research Foundation have served medicine and research for over 100 years through 4 generations. With the advent of Mana autologous DNA and Stem cell therapy for the last 13 years over 18000 patients have been successfully treated. Taking research and development to the next level through the medium of the convention we invite you to partake in this extravaganza of 3 days of didactic lectures, panel discussions, wet labs and interaction with like-minded people from the industry, the Government and autonomous bodies.

The partners for the conference include Niti Aayog, DRDO, IISc, Amity University, ICMR, Parmarthniketan, Lifecell. Important dignitaries attending the conference are DR.V.K.SARASWATH from Niti Aayog, SWAMY CHIDANAND SARASWATI from Parmarth Niketan, Rishikesh, DR.GERARD WAGEMAKER from Netherlands representing the Netherlands Society for Gene and Cell Therapy, DR.W.SELVAMURTHY and DR.B.C.DAS from Amity University, DR.SOWMYA SWAMINATHAN from ICMR, DR. SIVA UMAPATHY from IISc, DR.MIR POOYA from Iran, DR.P.S.DHOT from Lifecell International.

Scientific bodies are cordially invited to register for the convention as delegates, Interested persons may send in for Trade exhibits, and submit abstracts for free papers and instruction courses. You may visit www.isgct.in for more details and send a cheque or demand draft of Rs 4500 for delegate registration addressed to Gene Research Foundation, Bengaluru

Some of the salient topics that will be covered during the convention:

  1. CLINICAL BREAKTHROUGHS
  2. GENOME EDITING
  3. AUTOLOGOUS DNA AND STEM CELL THERAPY
  4. NEXT GEN SEQUENCING
  5. IN VITRO FERTILIZATION
  6. CARDIAC NEURO CANCER RESEARCH COMMERCIALIZATION

Dr Agarwal Hospitals

Gene Research Foundation

15 Eagle St, Langford Town

Bangalore 560025

Mobile: +919845010510 / 9886000777 
Fax: +918022221941

P.S: Kindly confirm your attendance by sending us a confirmation mail along with a photocopy of your valid passport, PAN card, Adhar card, driving licence or any other relevant ID for any further assistance like visa requirements for international participants.

For further assistance, contact us: Email Id:  generesearchfoundation@gmail.com

M: +91 9845010510

Corporate Comm India(CCI Newswire)

The Pharma Times News Bureau

Recent Posts

Dr. Narendranadh Meda Introduces Esaote’s Cutting-Edge O-Scan MRI Machine to Enhance Podiatric (Foot and Ankle) care in Hyderabad

Hyderabad, December 26, 2024: Dr. Narendranadh Meda, one of the city’s leading Vascular, Endovascular &…

18 hours ago

A Breakthrough in India’s Medical Industry: Bangalore Hospitals Introduces the First 640 Slice CT Scan Imaging

Bangalore, December 26, 2024: Bangalore Hospitals, a renowned brand in healthcare innovation and quality, has introduced…

18 hours ago

8 Ways Insomnia Affects Skin Health & How To Avoid It

By Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru Insomnia, the persistent inability…

6 days ago

Breaking New Ground in Migraine Care: A Landmark Session on Diagnosis and Treatment

Illuminating Latest Advances in Migraine Diagnosis and Treatment New Delhi, December 21, 2024: In a…

6 days ago

Healthcare Startups to Watch Out for in 2025

New Delhi, December 20, 2024: The healthcare sector is undergoing a transformation fueled by technological…

7 days ago

DKMS’s First Global Impact Report of 2023 Serves as New Ray of Hope for Blood Cancer Patients Worldwide

National, December 20, 2024: DKMS just published its first Global Impact Report that outlines the organization's…

7 days ago